The purpose of this study is to evaluate the drug concentrations of AzaSite™ compared to Vigamox at various time points in conjunctiva tissue of healthy volunteers
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Enrollment
48
azithromycin topical solution 1% given as a single drop in a single eye
Moxifloxacin topical solution given as a single drop in a single eye
Assessment of Pharmacokinetic Parameters
Time frame: Up to 24 hours
Assessment of Pharmacokinetic Parameters
Conjunctiva Concentration of Azithromycin and Moxifloxacin
Time frame: Over 24 hours
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.